天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

benzyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate

benzyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate Struktur
1554141-63-7
CAS-Nr.
1554141-63-7
Englisch Name:
benzyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate
Synonyma:
(3R,4R)-Benzyl 3-fluoro-4-hydroxypiperidine-1-carboxylate;benzyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate;1-Piperidinecarboxylic acid, 3-fluoro-4-hydroxy-, phenylmethyl ester, (3R,4R)-
CBNumber:
CB33121927
Summenformel:
C13H16FNO3
Molgewicht:
253.27
MOL-Datei:
1554141-63-7.mol

benzyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate Eigenschaften

Siedepunkt:
393.4±42.0 °C(Predicted)
Dichte
1.26±0.1 g/cm3(Predicted)
pka
13?+-.0.40(Predicted)

Sicherheit

RIDADR  UN2811

benzyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

benzyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


benzyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207
sales@molcore.com China 49734 58
Aceschem Inc.
+1-817863-6948 +1-(817)863-6948
sales@aceschem.com United States 19632 58
Suzhou ARTK Medchem Co., Ltd.
+86-512-68323658 +86-18168183658
sales1@artkmedchem.com China 39004 58
Aikon International Limited 025-66028182 18112977050
cfzhang@aikonchem.com China 15818 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 4000255188
sales_china@pharmablock.com China 9786 58
Synthonix Inc --
info@synthonix.com United States 6872 58

  • benzyl (3R,4R)-3-fluoro-4-hydroxypiperidine-1-carboxylate
  • (3R,4R)-Benzyl 3-fluoro-4-hydroxypiperidine-1-carboxylate
  • 1-Piperidinecarboxylic acid, 3-fluoro-4-hydroxy-, phenylmethyl ester, (3R,4R)-
  • 1554141-63-7
Copyright 2019 ? ChemicalBook. All rights reserved